2025-05-02 10:17:27
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Sun Pharma Advanced Research Company Ltd reports profit in Q3FY23
Posted On : 2023-02-14 20:20:01( TIMEZONE : IST )
Sun Pharma Advanced Research Company Limited has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 131.12 crores during the period ended December 31, 2022 as compared to Rs. 31.60 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 10.15 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -68.40 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.35 for the period ended December 31, 2022 as compared to Rs. -2.52 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹131.12 crs | ₹31.60 crs |  314.94% |
| Net Profit | ₹10.15 crs | ₹-68.40 crs | 114.84% |
| EPS | ₹0.35 | ₹-2.52 | 113.89% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.131.12 crores during the period ended December 31, 2022 as compared to Rs.62.49 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.10.15 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-15.84 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.35 for the period ended December 31, 2022 as compared to Rs.-0.60 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹131.12 crs | ₹62.49 crs | 109.83% |
| Net Profit | ₹10.15 crs | ₹-15.84 crs | 164.08% |
| EPS | ₹0.35 | ₹-0.60 | 158.33% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.191.24 crores during the 9 Months period ended December 31, 2022 as compared to Rs.118.63 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-140.59 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.-132.35 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.-5.16 for the 9 Months period ended December 31, 2022 as compared to Rs.-5.05 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹191.24 crs | ₹118.63 crs | 61.21% |
| Net Profit | ₹-140.59 crs | ₹-132.35 crs |  6.23% |
| EPS | ₹-5.16 | ₹-5.05 | 2.18% |
Shares of Sun Pharma Advanced Research Company Limited was last trading in BSE at Rs. 200.70 as compared to the previous close of Rs. 220.70. The total number of shares traded during the day was 143221 in over 3677 trades.
The stock hit an intraday high of Rs. 218.80 and intraday low of 197.55. The net turnover during the day was Rs. 29711460.00.
